SEC Form 4 · accession 0001225208-15-012206

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CVP, Heart Valve Therapy

Period of report

May 13, 2015

Accepted (ET)

May 15, 2015 · 6:26 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001099800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	May 13, 2015	M	2,141	$0.00	A	19,214	D
Common Stock^F3	holding	—	—		—	6,097	I	401(k)

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Performance Rights^F1	—	May 13, 2015	D	219	D	—	Mar 31, 2015	Common Stock	219	3,431	D
Performance Rights^F1	—	May 13, 2015	F	1,290	D	—	Mar 31, 2015	Common Stock	1,290	2,141	D
Performance Rights^F1,F4	—	May 13, 2015	M	2,141	D	—	Mar 31, 2015	Common Stock	2,141	0	D

F1On May 9, 2012, the reporting person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 13, 2015, 94% of the target shares vested and were issued and the balance of the award terminated.
F2This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This amount includes quarterly acquisition of shares under the Edwards Lifesciences Corporation Employee Stock Purchase Plan as reflected on the most recent report of the plan administrator.
F3Shares represented on the most recent statement of the 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equities to share equivalents.
F4This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.